McKesson Corporation (NYSE:MCK) dropped slightly amid mild profit booking and the last known price was $183.64 per share. The price decreased by -1.83 points or -0.99% which made the investors to buy on weakness. For the latest trading session, the net money flow was recorded at $16.56 million. The total upticks were valued at $74.63 million and the total downticks aggregated to $58.08 million, thereby putting the up/down ratio at 1.29,. The shares have seen a change in the share price of -1.51% on a weekly basis.In a big block trade which occurred today, the total uptick value was $17.73 million and the total downtick value was $0, resulting in an up/down ratio of 0. The net money flow for the block trade was calculated to be $17.73 million.
Currently the company Insiders own 1.5% of McKesson Corporation shares according to the proxy statements. In the past twelve weeks, the net percent change held by company insiders has changed by -88.46% . Institutional Investors own 87.88% of McKesson Corporation shares. During last six month period, the net percent change held by insiders has seen a change of -88.72%. On the companys insider trading activities,The director officer (Chairman, President & CEO) of Mckesson Corp, Hammergren John H sold 37,420 shares at $182.87 on May 24, 2016. The Insider selling transaction had a total value worth of $6,842,995. The Insider information was disclosed with the Securities and Exchange Commission in a Form 4 filing.
McKesson Corporation (NYSE:MCK) stock ended Monday session in the red zone in a volatile trading. The stock closed down 1.83 points or 0.99% at $183.64 with 1,440,768 shares getting traded. Post opening the session at $185.67, the shares hit an intraday low of $183.47 and an intraday high of $186.56 and the price was in this range throughout the day. The company has a market cap of $41,323 million and the number of outstanding shares have been calculated to be 225,020,520 shares. The 52-week high of McKesson Corporation (NYSE:MCK) is $238.5 and the 52-week low is $148.29.
Many analysts have stated their opinion on the company shares. Bank of America reinstates their rating on the shares of McKesson Corporation (NYSE:MCK). The current rating of the shares is Neutral. The rating by the firm was issued on June 7, 2016.
McKesson Corporation (McKesson) is engaged in delivering pharmaceuticals, medical supplies and healthcare information technology. The Company operates through two business segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment, and health and beauty care products across North America and internationally. The Distribution Solutions segment provides pharmaceutical solutions for biotech and pharmaceutical manufacturers, and practice management, technology, clinical support and business solutions to oncology and other specialty practices operating in the community setting. The Technology Solutions segment delivers clinical, patient care, financial, supply chain and strategic management software solutions, as well as connectivity, outsourcing and other services, including remote hosting and managed services, to healthcare organizations.